Halozyme Therapeutics, Inc. (HALO)

NASDAQ: HALO · Real-Time Price · USD

80.37

-1.20 (-1.47%)

At close: Jul 8, 2026, 4:00 PM EDT

80.37

0.00 (0.00%)

Pre-market: Jul 9, 2026, 5:46 AM EDT

Halozyme Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	1,508	1,397	1,015	829.25	660.12	443.31
Revenue Growth (YoY)	39.12%	37.55%	22.44%	25.62%	48.91%	65.66%
Cost of Revenue	259.61	228.77	159.42	192.36	139.3	81.41
Gross Profit	1,249	1,168	855.91	636.89	520.81	361.9
Selling, General & Admin	222.61	207.09	154.34	149.18	143.53	50.32
Depreciation & Amortization Expenses	88.41	76.66	71.05	73.77	43.15	-
Research & Development	92.25	81.49	79.05	76.36	66.61	35.67
Other Operating Expenses	-	333.59	-	-	-	-
Total Operating Expenses	403.27	698.83	304.43	299.32	253.28	86
Operating Income	511.99	469.01	551.48	337.57	267.53	275.9
Interest Income	15.97	21.47	23.75	16.32	1.05	1.1
Interest Expense	-19.11	-18.13	-18.1	-18.76	-16.95	-7.53
Other Non-Operating Income (Expense)	-	-5.48	-	13.2	-2.71	-20.96
Total Non-Operating Income (Expense)	-3.14	-2.13	5.66	10.76	-18.61	-27.38
Pretax Income	503.37	466.88	557.13	348.33	248.92	248.52
Provision for Income Taxes	154.53	149.99	113.04	66.74	46.79	-154.19
Net Income	348.84	316.89	444.09	281.59	202.13	402.71
Net Income to Common	348.84	316.89	444.09	281.59	202.13	402.71
Net Income Growth	-28.13%	-28.64%	57.71%	39.31%	-49.81%	211.97%
Shares Outstanding (Basic)	119	120	127	132	137	141
Shares Outstanding (Diluted)	122	124	129	134	141	147
Shares Change (YoY)	-5.43%	-4.26%	-3.56%	-4.56%	-4.21%	3.77%
EPS (Basic)	2.92	2.64	3.50	2.13	1.48	2.86
EPS (Diluted)	2.78	2.56	3.43	2.10	1.44	2.74
EPS Growth	-26.06%	-25.36%	63.33%	45.83%	-47.45%	201.10%
Free Cash Flow	667.65	644.59	468.37	373.28	235.3	297.98
Free Cash Flow Growth	3.58%	37.62%	25.47%	58.64%	-21.04%	462.76%
Free Cash Flow Per Share	5.48	5.20	3.62	2.78	1.67	2.03
Gross Margin	82.79%	83.62%	84.30%	76.80%	78.90%	81.64%
Operating Margin	33.94%	33.58%	54.32%	40.71%	40.53%	62.24%
Profit Margin	23.13%	22.69%	43.74%	33.96%	30.62%	90.84%
FCF Margin	44.26%	46.15%	46.13%	45.01%	35.65%	67.22%
EBITDA	613.32	557.06	632.79	422.43	317.17	278.9
EBITDA Margin	40.66%	39.89%	62.32%	50.94%	48.05%	62.91%
EBIT	511.99	469.01	551.48	337.57	267.53	275.9
EBIT Margin	33.94%	33.58%	54.32%	40.71%	40.53%	62.24%
Effective Tax Rate	30.70%	32.13%	20.29%	19.16%	18.80%	-62.04%

SEC Filings: 10-K · 10-Q